As the digital assets market began the second quarter in a state of consolidation, Fidelity Digital Assets observed that underlying trends suggest early signs of market stabilization. In its Q2 2026 Signals Report, published on Monday, the firm highlighted enhancements across several key metrics, including unrealized profit, momentum, and network usage, offering a more nuanced view beyond price fluctuations. The report examines the dynamics of risk, positioning, and market cycles for bitcoin, ether, and solana.

Bitcoin, the largest cryptocurrency, continues to be the primary source of market resilience, with indicators of unrealized profit and dominance signifying that capital remains concentrated in the most established and liquid assets during this consolidation phase. Analysts noted that bitcoin's dominance has been gradually increasing after a decline in the latter half of 2025. With bitcoin trading around $77,000 at the time of publication, the crypto market has experienced a mixed performance recently, with major tokens like bitcoin and ether largely trading within a range as investors navigate complex macroeconomic conditions. Factors such as persistent inflation, shifting expectations around central bank rate cuts, and periodic volatility in global equities have dampened risk appetite, while ongoing regulatory scrutiny has added to the uncertainty.

Furthermore, conflicts and trade tensions between major economies have led to bouts of risk aversion, limiting the upside in digital assets. However, the analysts observed that indicators of momentum and profitability are consistent with a corrective phase, potentially laying the groundwork for a more stable market.

A notable discrepancy is emerging between price movements and network activity, with sustained usage on Ethereum and Solana suggesting that demand at the protocol level remains robust, even as valuations lag. These signals collectively point to a market in recovery, with structural improvements underway that may not yet be fully reflected in current prices.